Ahmed Mahiuddin

Sr. VP and CSO at Y-mAbs Therapeutics, Inc.

Sold, on record
$4.3M
Dollars the filings state
Form 4 sales
4
Latest May 26, 2020
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not stated
    May 12, 2020 2020

    Sold 20,000 shares at $39.19 ($784k)

    Ahmed Mahiuddin, Sr. VP and CSO

    Sold 7.7% of holdings ($10.2M position)240,000 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not stated
    May 13, 2020 +1 day

    Sold 10,508 shares at $37.64 ($396k)

    Ahmed Mahiuddin, Sr. VP & Chief Scientific Off

    Sold 4.4% of holdings ($9M position)229,492 shares leftFiling

  3. 3 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not stated
    May 19, 2020 +6 days

    Sold 29,492 shares at $39.41 ($1.2M)

    Ahmed Mahiuddin, Sr. VP and CSO

    Sold 12.9% of holdings ($9M position)200,000 shares leftFiling

  4. 4 Form 4 sale Y-mAbs Therapeutics, Inc.Unusual
    May 26, 2020 +7 days

    Sold 50,000 shares at $39.38 ($2M)

    Ahmed Mahiuddin, Sr. VP and CSO

    Sold 25% of holdings ($7.9M position)150,000 shares left2.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Ahmed Mahiuddin
Source
May 26, 2020May 27, 2020Y-mAbs Therapeutics, Inc.Sr. VP and CSOForm 4 sale50,000$2M25.0%UnusualSEC
May 19, 2020May 20, 2020Y-mAbs Therapeutics, Inc.Sr. VP and CSOForm 4 sale29,492$1.2M12.9%Plan not statedSEC
May 13, 2020May 15, 2020Y-mAbs Therapeutics, Inc.Sr. VP & Chief Scientific OffForm 4 sale10,508$396k4.4%Plan not statedSEC
May 12, 2020May 13, 2020Y-mAbs Therapeutics, Inc.Sr. VP and CSOForm 4 sale20,000$784k7.7%Plan not statedSEC